Aaron Ring

Aaron Ring was born in 1978 and grew up in the suburbs of Boston. Aaron attended Yale University for their undergraduate degree, where they majored in Biology and performed research on the molecular genetics of hypertension in the laboratory of Richard Lifton. Aaron then went on to Stanford University School of Medicine for their MD/PhD, where they completed their PhD in Structural Biology in the laboratories of K. Christopher Garcia and Irving Weissman concurrently with their medical training. Aaron's research focused on using directed evolution to engineer new immunomodulatory agents for the treatment of cancer and autoimmune disease. Additionally, they developed new methodologies with Brian Kobilka's laboratory to extend combinatorial techniques to integral membrane proteins such as G-protein coupled receptors.

After finishing their MD/PhD, Aaron became an Assistant Professor of Immunobiology at the Yale School of Medicine, where they continued their research on developing new immunomodulatory agents. In 2013, they left Yale to start their own company, Seranova Bio, which is focused on developing new therapies for cancer and autoimmune diseases. Aaron is also the founder of Simcha Therapeutics, a company that is developing new treatments for inflammatory diseases.